Shunsuke Hamada Selected Research

Aggressive Fibromatosis (Desmoid)

1/2022	Efficacy of auranofin as an inhibitor of desmoid progression.
11/2021	Trends in diagnostic and therapeutic strategies for extra-abdominal desmoid-type fibromatosis: Japanese musculoskeletal oncology group questionnaire survey.
11/2020	Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial.
9/2020	Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
9/2020	Is tumour location a prognostic factor for pharmacological treatment in patients with desmoid-type fibromatosis? a systematic review.
4/2020	Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
12/2019	MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid-type fibromatosis.
1/2019	Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study.
8/2017	Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis.
8/2016	Simple resection of truncal desmoid tumors: A case series.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shunsuke Hamada Research Topics

Disease

14	Aggressive Fibromatosis (Desmoid) 01/2022 - 01/2014
12	Neoplasms (Cancer) 01/2021 - 01/2014
9	Fibroma (Fibromatosis) 01/2022 - 08/2017
4	Neoplasm Metastasis (Metastasis) 01/2017 - 08/2014
3	Neurofibrosarcoma (MPNST) 01/2021 - 08/2014
2	Crohn Disease (Crohn's Disease) 02/2020 - 01/2018
2	Chondrosarcoma 01/2020 - 01/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2019 - 01/2018
1	Diabetes Mellitus 02/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Neutropenia 01/2021
1	Osteoporosis 01/2021
1	Pain (Aches) 04/2020
1	Body Weight (Weight, Body) 02/2020
1	Leukopenia 10/2019
1	Osteoarthritis 01/2017
1	Pigmented Villonodular Synovitis 07/2015
1	Disease Progression 07/2015
1	Hyperthermia 02/2015
1	Osteosarcoma (Osteogenic Sarcoma) 06/2014

Drug/Important Bio-Agent (IBA)

8	CateninsIBA 11/2020 - 01/2014
6	Meloxicam (Mobic)FDA LinkGeneric 12/2019 - 01/2014
4	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 08/2014
3	Vinblastine (Vinblastine Sulfate)FDA Link 11/2020 - 12/2015
3	Methotrexate (Mexate)FDA LinkGeneric 11/2020 - 12/2015
3	Pharmaceutical PreparationsIBA 09/2020 - 01/2018
2	AlbuminsIBA 02/2020 - 01/2017
2	Infliximab (Remicade)FDA Link 02/2020 - 01/2018
2	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2020 - 01/2017
2	HymecromoneIBA 01/2018 - 01/2017
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2017 - 12/2015
2	Proteins (Proteins, Gene)FDA Link 07/2015 - 08/2014
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2014 - 01/2014
1	Auranofin (Ridaura)FDA Link 01/2022
1	pazopanib FDA Link 01/2021
1	Diphosphonates (Bisphosphonates)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Lipase (Acid Lipase)FDA Link 01/2021
1	SteroidsIBA 01/2021
1	Therapeutic UsesIBA 09/2020
1	Alcian BlueIBA 01/2020
1	NucleosidesIBA 10/2019
1	Diphosphates (Pyrophosphates)IBA 10/2019
1	2-mercaptopurineIBA 10/2019
1	Biological ProductsIBA 06/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	Protons (Proton)IBA 12/2016
1	Macrophage Colony-Stimulating FactorIBA 07/2015
1	Ferrosoferric Oxide (Magnetite)FDA Link 02/2015
1	Liposomes (Liposome)IBA 02/2015
1	AlginatesIBA 02/2015
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 06/2014
1	Matrix Metalloproteinases (MMPs)IBA 06/2014

Therapy/Procedure

7	Therapeutics 01/2020 - 01/2014
5	Drug Therapy (Chemotherapy) 01/2021 - 12/2015
4	Conservative Treatment 11/2021 - 01/2014
1	Treatment Delay 02/2022
1	Molecular Targeted Therapy 01/2022
1	Activities of Daily Living (ADL) 11/2021
1	Radiotherapy 12/2016